China's inactivated COVID-19 vaccine candidate shows promising results in two phase trials

China unveiled the results of the phase 1 and phase 2 clinical trials of an inactivated COVID-19 vaccine candidate, which shows promising results in both safety and efficacy. The chief scientist of its developer explains more.